1. (a) Health authorities may assist in conducting lead investigations under He-P 1600 in accordance with RSA 130-A:5, III, by providing the following types of assistance:

   1. (1) Contacting owners or occupants to schedule an environmental inspection;
   2. (2) Gathering information as described in He-P 1604.02; and
   3. (3) Any other assistance requested by the commissioner to aid in conducting a lead investigation.

2. (b) In accordance with RSA 130-A:11, III, the commissioner shall approve a health authority to carry out lead investigations upon submission of the following to the department:

   1. (1) A request in writing to the commissioner for approval to conduct lead investigations;

   2. (2) Documentation of the health authority’s attendance and successful completion of one of the following:

      1. a. An educational program for lead inspectors that is certified in accordance with He-P 1611; or
      2. b. An educational program for risk assessors that is certified in accordance with He-P 1611;
   3. (3) Documentation that the health authority meets all of the criteria for field use of a XRF in accordance with He-P 1608.04(d); and

   4. (4) Written assurance that the health authority will:

      1. a. Conduct lead investigations in accordance with RSA 130-A:5 and 6, and this chapter; and
      2. b. Submit copies of all lead investigation related documents, such as environmental inspection results, to the department.
3. (c) Approval for a health authority to conduct lead investigations and environmental inspections shall be valid for a period of 12 months.

4. (d) The commissioner shall renew the approval upon submission of the following by the health authority to the department:

   1. (1) A request in writing to the commissioner for renewal of approval to conduct lead investigations;
   2. (2) When applicable, documentation of attendance and successful completion by the health authority of an approved lead inspector or risk assessor refresher training program as described in He-P 1611 and He-P 1612;
   3. (3) Documentation that the health authority meets all of the criteria for field use of a XRF in accordance with He-P 1608.04(d); and
   4. (4) A written assurance that the health authority will conduct lead investigations in accordance with RSA 130-A:5 and 6, and this chapter.
5. (e) The commissioner shall deny or revoke such approval in accordance with He-P 1606.02.

Source. #9986, eff 9-1-11 (from He-P 1612.05), EXPIRED: 9-1-19 New. #13052, eff 6-11-20; ss by #14230, eff 4-2-25